BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor letter (Rote Hand Brief) on Cardioxane®: Secondary neoplasia in children

Active substance: dexrazoxane

Important safety information on Cardioxane® (dexrazoxane) and increased risk for secondary neoplasia in children.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 1MB, File is accessible